Correlation between high blood IL-6 level, hyperglycemia, and glucose control in septic patients

Critical Care

Volumn 16, Issue 2, 2012, Pages

  Nakamura, Masataka ^a   Oda, Shigeto ^a   Sadahiro, Tomohito ^a   Watanabe, Eizo ^a   Abe, Ryuzo ^a   Nakada, Taka aki ^a   Morita, Yasumasa ^a   Hirasawa, Hiroyuki ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INTERLEUKIN 6; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CALORIC INTAKE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE STORM; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; STEROID THERAPY; SURVIVAL RATE; UNIVERSITY HOSPITAL; ANALYSIS; BLOOD; CHI SQUARE DISTRIBUTION; DIABETES MELLITUS; MIDDLE AGED; RETROSPECTIVE STUDY;

BIOMARKERS; BLOOD GLUCOSE; CHI-SQUARE DISTRIBUTION; DIABETES MELLITUS; FEMALE; HUMANS; HYPERGLYCEMIA; INTERLEUKIN-6; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEPSIS; SURVIVAL RATE;

EID: 84859509011     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11301     Document Type: Article

References (29)

1. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000, 355:773-778. 10.1016/S0140-6736(99)08415-9, 10711923.
2. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001, 32:2426-2432. 10.1161/hs1001.096194, 11588337.
3. Rovlias A, Kotsou S. The influence of hyperglycemia on neurological outcome in patients with severe head injury. Neurosurgery 2000, 46:335-342. 10.1097/00006123-200002000-00015, 10690722.
4. Marik PE. Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med 2004, 30:748-756. 10.1007/s00134-004-2167-y, 14991101.
5. Van Cromphaut SJ, Vanhorebeek I, Van den Berghe G. Glucose metabolism and insulin resistance in sepsis. Curr Pharm Des 2008, 14:1887-1899. 10.2174/138161208784980563, 18691100.
6. Losser MR, Damoisel C, Payen D. Bench-to-bedside review: Glucose and stress conditions in the intensive care unit. Crit Care 2010, 14:231. 10.1186/cc9100, 2945096, 20727232.
7. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004, 30:536-555. 10.1007/s00134-004-2210-z, 14997291.
8. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008, 34:17-60. 10.1007/s00134-007-0934-2, 2249616, 18058085.
9. Implement the Management Bundle within First 24 Hours of Care. , http://www.survivingsepsis.org/Bundles/Pages/SepsisManagementBundle.aspx
10. Gustot T. Multiple organ failure in sepsis: prognosis and role of systemic inflammatory response. Curr Opin Crit Care 2011, 17:153-159. 10.1097/MCC.0b013e328344b446, 21346564.
11. Abraham E, Mervyn S. Mechanisms of sepsis-induced organ dysfunction. Crit Care Med 2007, 35:2408-2416. 10.1097/01.CCM.0000282072.56245.91, 17948334.
12. Oda S, Hirasawa H, Shiga H, Nakanishi K, Matsuda K, Nakamura M. Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis. Cytokine 2005, 29:169-175. 10.1016/j.cyto.2004.10.010, 15652449.
13. Abe R, Oda S, Sadahiro T, Nakamura M, Hirayama Y, Tateishi Y, Shinozaki K, Hirasawa H. Gram-negative bacteremia induces greater magnitude of inflammatory response than Gram-positive bacteremia. Crit Care 2010, 14:R27. 10.1186/cc8898, 2887127, 20202204.
14. Kellum JA, Kong L, Fink MP, Weissfeld LA, Yealy DM, Pinsky MR, Fine J, Krichevsky A, Delude RL, Angus DC, . GenIMS Investigators Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med 2007, 167:1655-1663. 10.1001/archinte.167.15.1655, 17698689, GenIMS Investigators.
15. Tschaikowsky K, Hedwig-Geissing M, Braun GG, Radespiel-Troeger M. Predictive value of procalcitonin, interleukin-6, and C-reactive protein for survival in postoperative patients with severe sepsis. J Crit Care 2011, 26:54-64. 10.1016/j.jcrc.2010.04.011, 20646905.
16. Gregoric P, Sijacki A, Stankovic S, Radenkovic D, Ivancevic N, Karamarkovic A, Popovic N, Karadzic B, Stijak L, Stefanovic B, Milosevic Z, Bajec D. SIRS score on admission and initial concentration of IL-6 as severe acute pancreatitis outcome predictors. Hepatogastroenterology 2010, 57:349-353.
17. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20:864-874. 10.1097/00003246-199206000-00025, 1597042, American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee.
18. Grimble RF. Inflammatory status and insulin resistance. Curr Opin Clin Nutr Metab Care 2002, 5:551-559. 10.1097/00075197-200209000-00015, 12172480.
19. Petit F, Bagby GJ, Lang CH. Tumor necrosis factor mediates zymosan-induced increase in glucose flux and insulin resistance. Am J Physiol 1995, 268:E219-E228.
20. Rotter V, Nagaev I, Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 2003, 278:45777-45784. 10.1074/jbc.M301977200, 12952969.
21. Müller S, Martin S, Koenig W, Hanifi-Moghaddam P, Rathmann W, Haastert B, Giani G, Illig T, Thorand B, Kolb H. Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors. Diabetologia 2002, 45:805-812. 10.1007/s00125-002-0829-2, 12107724.
22. Katsuki A, Sumida Y, Murashima S, Murata K, Takarada Y, Ito K, Fujii M, Tsuchihashi K, Goto H, Nakatani K, Yano Y. Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1998, 83:859-862. 10.1210/jc.83.3.859, 9506740.
23. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K, . German Competence Network Sepsis (SepNet) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008, 358:125-139. 10.1056/NEJMoa070716, 18184958, German Competence Network Sepsis (SepNet).
24. Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ. NICE-SUGAR Study Investigators Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009, 360:1283-1297. NICE-SUGAR Study Investigators.
25. Eslami S, Abu-Hanna A, de Keizer NF, Bosman RJ, Spronk PE, de Jonge E, Schultz MJ. Implementing glucose control in intensive care: a multicenter trial using statistical process control. Intensive Care Med 2010, 36:1556-1565. 10.1007/s00134-010-1924-3, 2926931, 20533024.
26. Meyfroidt G, Wouters P, De Becker W, Cottem D, Van den Berghe G. Impact of a computer-generated alert system on the quality of tight glycemic control. Intensive Care Med 2011, 37:1151-1157. 10.1007/s00134-011-2159-7, 21369814.
27. Hanazaki K, Maeda H, Okabayashi T. Tight perioperative glycemic control using an artificial endocrine pancreas. Surg Today 2010, 40:1-7. 10.1007/s00595-009-4061-2, 20037833.
28. Rimmelé T, Kellum JA. Clinical review: Blood purification for sepsis. Crit Care 2011, 15:205. 3222040, 21371356.
29. Nakamura M, Oda S, Sadahiro T, Hirayama Y, Watanabe E, Tateishi Y, Nakada TA, Hirasawa H. Treatment of severe sepsis and septic shock by CHDF using a PMMA membrane hemofilter as a cytokine modulator. Contrib Nephrol 2010, 166:73-82.